03907nam a22007815i 45000010014000000030009000140050017000230060019000400070015000590080041000740200018001150240031001330350020001640350022001840400033002060410008002390440011002470720023002581000082002812450077003632500017004402640053004572640011005103000048005213360026005693370026005953380036006213470024006574900034006815051383007155060104020985380049022025460016022515880112022676500016023796500038023956500018024336500051024517730115025027760025026178560042026428560068026849120016027529120014027689120016027829120014027989120017028129120015028299120015028449120017028599120016028769120016028929120016029089120015029249120015029399120024029549120014029789120014029929120013030069120013030199120015030329120012030479120009030599120012030689120012030809120012030929120021031049783110851724DE-B159720191221113333.0m|||||o||d||||||||cr || ||||||||191221s2019    gw     fo  d z      eng d  a97831108517247 a10.1515/97831108517242doi  a(DE-B1597)55354  a(OCoLC)1125188447  aDE-B1597bengcDE-B1597erda0 aeng  agwcDE 7aMED0270002bisacsh1 aNortier, J. W. R., eauthor.4aut4http://id.loc.gov/vocabulary/relators/aut.10aAdjunctive Medical Therapy for Acromegalic Patients /cJ. W. R. Nortier.  aReprint 2019 1aBerlin ;aBoston : bDe Gruyter Mouton, c[2019] 4cÂ©1984  a1 online resource (X, 91 p.) :bNum. tables  atextbtxt2rdacontent  acomputerbc2rdamedia  aonline resourcebcr2rdacarrier  atext filebPDF2rda0 aClinical research series ;v200tFrontmatter -- tList of abbreviations -- tContents -- tCHAPTER I. Introduction -- tCHAPTER II. Plasma growth hormone suppressive effect of bromocriptine in acromegaly. Evaluation by plasma GH day profiles and plasma GH concentrations during oral glucose tolerance tests / rNortier, J.W.R. / Croughs, R.J.M. / Thijssen, J.H.H. / Schwarz, F. -- tCHAPTER III. Changes in plasma GH levels and clinical activity during bromocriptine therapy in acromegaly. The value of predictive tests / rNortier, J.W.R. / Croughs, R.J.M. / Donker, G.H. / Thijssen, J.H.H. / Schwarz, F. -- tCHAPTER IV. Bromocriptine therapy in acromegaly: effects on plasma GH levels, somatomedin-C levels and clinical activity / rNortier, J.W.R. / Croughs, R.J.M. / Thijssen, J.H.H. / Schwarz, F. -- tCHAPTER V. Gel filtration studies of plasma growth hormone in bromocriptine treated acromegaly: correlations with somatomedin-C and clinical response / rNortier, J.W.R. / Croughs, R.J.M. / Donker, G.H. / Thijssen, J.H.H. / Schwarz, F. -- tCHAPTER VI. No acute effect of pimozide on the plasma GH levels in acromegaly / rNortier, J.W.R. / Croughs, R.J.M. / Donker, G.H. / Thijssen, J.H.H. / Schwarz, F. -- tCHAPTER VII. Long-term follow-up of five untreated acromegalic patients / rNortier, J.W.R. / Croughs, R.J.M. / Thijssen, J.H.H. / Schwarz, F. -- tCHAPTER VIII. General discussion -- tSummary0 arestricted accessuhttp://purl.org/coar/access_right/c_16ecfonline access with authorization2star  aMode of access: Internet via World Wide Web.  aIn English.0 aDescription based on online resource; title from PDF title page (publisher's Web site, viewed 21. Dez 2019) 4aAcromegaly. 4aBromocriptine -- Therapeutic use. 4aSomatotropin. 7aMEDICAL / Endocrinology & Metabolism.2bisacsh08iTitle is part of eBook package:dDe GruytertDGBA Linguistics and Semiotics - <1990z9783110636772oZDB-23-DLS0 cprintz978311013365340uhttps://doi.org/10.1515/9783110851724423Coveruhttps://www.degruyter.com/cover/covers/9783110851724.jpg  aEBA_BACKALL  aEBA_CL_LS  aEBA_CL_MDPM  aEBA_DGALL  aEBA_EBACKALL  aEBA_EBKALL  aEBA_ECL_LS  aEBA_ECL_MDPM  aEBA_EEBKALL  aEBA_ESSHALL  aEBA_ESTMALL  aEBA_SSHALL  aEBA_STMALL  aGBV-deGruyter-alles  aPDA11SSHE  aPDA13ENGE  aPDA14ALL  aPDA16SSH  aPDA17SSHEE  aPDA1ALL  aPDA2  aPDA2HUM  aPDA5EBK  aPDA7ENG  aZDB-23-DLSb1990